Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/Core EBITDA(x) 21.6624.4518.2430.428.26

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 21.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.66
Mar202424.45
Mar202318.24
Mar202230.42
Mar20178.26

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2025 21.66
-11.41
Mar2024 24.45
34.05
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,333.9 Cr 3.2% -1.1% -17.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,591.0 Cr 3.2% 12.4% 11.5% Stock Analytics
DIVIS LABORATORIES ₹183,512.0 Cr 1.8% 11% 10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,850.0 Cr 3.8% 6.7% 35.5% Stock Analytics
CIPLA ₹113,884.0 Cr 6.2% 13.9% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹111,339.0 Cr 5.4% 8% 9.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

3.2%

-1.1%

-17.4%

SENSEX

0.9%

-3.6%

-7.3%


You may also like the below Video Courses